Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging

被引:69
|
作者
Savoiardo, M [1 ]
机构
[1] Ist Nazl Neurol C Besta, Dept Neuroradiol, Milan, Italy
关键词
magnetic resonance imaging; Parkinson's disease; atypical parkinsonian disorders; multiple system atrophy; progressive supranuclear palsy;
D O I
10.1007/s100720300036
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance imaging (MRI) is not usually considered helpful for establishing the diagnosis of Parkinson's disease, but it is much more important to support the clinical diagnosis in atypical parkinsonian disorders. In multiple system atrophy with predominant parkinsonian features (MSA-P), MRI demonstrates putaminal abnormalities due to loss of neurons and gliosis and accumulation of iron in the posterior lateral part of the nucleus. When cerebellar features are present (MSA-C), pontine and cerebellar atrophy is seen with signal abnormalities that correspond to the distribution of the degenerative changes. In progressive supranuclear palsy, the main abnormality is atrophy of the midbrain. Mild-to-moderate cerebral atrophy may be present, but more-marked asymmetrical atrophy in the posterior frontal and parietal regions contralateral to the side of the clinical manifestations is characteristic of corticobasal degeneration.
引用
收藏
页码:S35 / S37
页数:3
相关论文
共 50 条
  • [21] Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders
    Kowalska-Taczanowska, Renata
    Friedman, Andrzej
    Koziorowski, Dariusz
    BRAIN AND BEHAVIOR, 2020, 10 (08):
  • [22] Differentiation of atypical parkinsonian syndromes and their separation from idiopathic Parkinson's disease by means of routine magnetic resonance imaging
    Csoti, I
    Warmuth-Metz, M
    Solymosi, L
    Becker, G
    Fornadi, F
    Naumann, M
    NERVENARZT, 2004, 75 (02): : 128 - 134
  • [23] Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: AMeta-Analysis
    Lee, Will
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (02): : 217 - 223
  • [24] Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Parkinsonian syndromes
    Schroeter, Nils
    van Eimeren, Thilo
    Classen, Joseph
    Levin, Johannes
    Redecker, Christoph
    Wolz, Martin
    Toenges, Lars
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (06) : 839 - 846
  • [25] CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
    Mondello, Stefania
    Constantinescu, Radu
    Zetterberg, Henrik
    Andreasson, Ulf
    Holmberg, Bjoern
    Jeromin, Andreas
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 382 - 387
  • [26] Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders
    Jaimini, Abhinav
    Tripathi, Madhavi
    D'Souza, Maria M.
    Panwar, Puja
    Sharma, Rajnish
    Mehta, Saloni
    Pandey, Santosh
    Saw, Sanjiv
    Singh, Dinesh
    Solanki, Yachna
    Mishra, Anil K.
    Mondal, Anupam
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (05) : 426 - 431
  • [27] Magnetic resonance imaging of the substantia nigra in Parkinson's disease
    Lehericy, Stephane
    Sharman, Michael A.
    Dos Santos, Clarisse Longo
    Paquin, Raphael
    Gallea, Cecile
    MOVEMENT DISORDERS, 2012, 27 (07) : 822 - 830
  • [28] Brain Magnetic Resonance Imaging Techniques in the Diagnosis of Parkinsonian Syndromes
    Seppi, Klaus
    Poewe, Werner
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2010, 20 (01) : 29 - +
  • [29] Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
    Savoie, Felix-Antoine
    Arpin, David J.
    Vaillancourt, David E.
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (10) : 1583 - 1605
  • [30] The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
    Chougar, Lydia
    Pyatigorskaya, Nadya
    Degos, Bertrand
    Grabli, David
    Lehericy, Stephane
    FRONTIERS IN NEUROLOGY, 2020, 11